not quite was I was hoping for re. sales............... but then pharma launch didn't happen till March/April and only third party products
Would have liked to see a better break-down re STI products etc
From this I can't see how research grants have been accounted for (proceeds from R&D/grants: 0,00?) and like to see a better break down of "Corporate and admin expense: 2,518,516.00
Guess we will get a better explanation during the AGM which must be scheduled soon
not being negative on STI but from an accounting point of view there are questions and we need to see an improvement in the sales figures - which can only happen once Canada is up and running
STI Price at posting:
1.1¢ Sentiment: Hold Disclosure: Held
